Corrigendum: Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium

Michaël R Laurent; Jean De Schepper; Dominique Trouet; Nathalie Godefroid; Emese Boros; Claudine Heinrichs; Bert Bravenboer; Brigitte Velkeniers; Johan Lammens; Pol Harvengt; Etienne Cavalier; Jean-François Kaux; Jacques Lombet; Kathleen De Waele; Charlotte Verroken; Koenraad van Hoeck; Geert R Mortier; Elena Levtchenko; Johan Vande Walle

doi:10.3389/fendo.2021.686401

Corrigendum: Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium

Front Endocrinol (Lausanne). 2021 May 25:12:686401. doi: 10.3389/fendo.2021.686401. eCollection 2021.

Authors

Michaël R Laurent¹, Jean De Schepper^{2

3}, Dominique Trouet^{4

5}, Nathalie Godefroid⁶, Emese Boros⁷, Claudine Heinrichs⁷, Bert Bravenboer⁸, Brigitte Velkeniers⁸, Johan Lammens⁹, Pol Harvengt¹⁰, Etienne Cavalier¹¹, Jean-François Kaux¹², Jacques Lombet¹³, Kathleen De Waele³, Charlotte Verroken¹⁴, Koenraad van Hoeck^{4

5}, Geert R Mortier¹⁵, Elena Levtchenko¹⁶, Johan Vande Walle¹⁷

Affiliations

¹ Centre for Metabolic Bone Diseases, University Hospitals Leuven, Leuven, Belgium.
² Division of Pediatric Endocrinology, KidZ Health Castle, University Hospital Brussels, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
³ Department of Pediatric Endocrinology, University Hospital Ghent, Ghent, Belgium.
⁴ Department of Pediatric Nephrology, Antwerp University Hospital, Antwerp, Belgium.
⁵ Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerp, Belgium.
⁶ Pediatric Nephrology, Cliniques Universitaires St. Luc (UCL), Brussels, Belgium.
⁷ Paediatric Endocrinology Unit, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, Brussels, Belgium.
⁸ Department of Endocrinology, University Hospital Brussels, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
⁹ Department of Orthopaedic Surgery and Department of Development and Regeneration, Prometheus LRD Division of Skeletal Tissue Engineering, KU Leuven - University Hospitals Leuven, Leuven, Belgium.
¹⁰ XLH Belgium, Belgian XLH patient association, Waterloo, Belgium.
¹¹ Department of Clinical Chemistry, University Hospital Center of Liège, University of Liège, Liège, Belgium.
¹² Physical Medicine, Rehabilitation and Sports Traumatology, University and University Hospital of Liège, Liège, Belgium.
¹³ Division of Nephrology, Department of Pediatrics, University Hospital Center of Liège, Liège, Belgium.
¹⁴ Unit for Osteoporosis and Metabolic Bone Diseases, Department of Endocrinology and Metabolism, Ghent University Hospital, Ghent, Belgium.
¹⁵ Department of Medical Genetics, Antwerp University Hospital and University of Antwerp, Antwerp, Belgium.
¹⁶ Department of Pediatrics/Pediatric Nephrology, University Hospitals Leuven, Leuven, Belgium.
¹⁷ Department of Pediatric Nephrology, University Hospital Ghent, Ghent, Belgium.

Abstract

[This corrects the article DOI: 10.3389/fendo.2021.641543.].

Keywords: Burosumab; X-linked hypophosphatemia; fibroblast growth factor 23; osteomalacia; rickets; vitamin D.

Copyright © 2021 Laurent, De Schepper, Trouet, Godefroid, Boros, Heinrichs, Bravenboer, Velkeniers, Lammens, Harvengt, Cavalier, Kaux, Lombet, De Waele, Verroken, van Hoeck, Mortier, Levtchenko and Vande Walle.

Publication types

Published Erratum